Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Dasutra X 30mg Tablets | 100-Count | DASATINIB
Pharma

Dasutra X 30mg Tablets | 100-Count | DASATINIB

$200

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse DASATINIB — 30mg per tablet, 100-count pack. Second-generation BCR-ABL/SRC kinase inhibitor for CML resistant to imatinib and Ph+ ALL. Also studied as senolytic agent in longevity medicine to clear senescent (zombie) cells. Key warning: Pleural effusion monitoring — may require dose interruption. QT monitoring. CYP3A4 interactions. Avoid antacids within 2 hours. Embryofetal toxicity.

SKU
VES-003403-DASUTRA-30MG-100TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Dasutra X 30mg (DASATINIB)?

Second-generation BCR-ABL/SRC kinase inhibitor for CML resistant to imatinib and Ph+ ALL. Also studied as senolytic agent in longevity medicine to clear senescent (zombie) cells.

How it Works

50x more potent than imatinib for BCR-ABL. Also inhibits SRC family kinases. As senolytic: promotes apoptosis of senescent cells in combination with quercetin.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
DASATINIB
Dose per Tablet
30MG
Pack Size
10×10 (100 tablets)
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Pleural effusion (fluid around lungs — unique to dasatinib), myelosuppression, QT prolongation, fluid retention, diarrhea, rash, hepatotoxicity.

Safety Warnings

Pleural effusion monitoring — may require dose interruption. QT monitoring. CYP3A4 interactions. Avoid antacids within 2 hours. Embryofetal toxicity. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.